Abstract 1755P
Background
Obesity is a strong risk factor for cancer, with more than 40,000 diagnosed cancers every year attributed to obesity. The role of nutrition in obesity-related cancers (ORC) needs to be better understood to develop tailored prevention strategies. The quality, rather than the quantity, of carbohydrate intake, seems to play a significant role. We investigated the relationship between dietary carbohydrate quality and risk of developing ORC in the "Seguimiento Universidad de Navarra” (SUN) Mediterranean cohort.
Methods
A total of 18,446 Spanish university graduates [mean age 38 years (SD 12), 61% women, mean BMI 23.5 kg/m2 (SD 3.5 kg/m2)], with no personal history of cancer, were followed-up for a median of 13.7 years. Baseline carbohydrate quality index (CQI) was assessed using 4 previously defined criteria: high dietary fibre intake, low glycemic index, high whole-grain: total-grain ratio and high solid carbohydrate: total carbohydrate ratio. Subjects were classified into tertiles according to their CQI score. Obesity-related incident cases were confirmed by an oncologist using medical records and by querying the National Death Index blindly to dietary exposures.
Results
During follow-up, 269 incident cases of obesity-related cancer were confirmed. A higher quality of carbohydrate intake, as measured by the baseline CQI, was associated with a lower risk of ORC with multivariable-adjusted hazard ratio (HR) for the upper (T3) versus the lowest tertile (T1) of 0.68 (95% confidence interval: 0.48, 0.97). Particularly, a higher dietary fibre intake was inversely associated with ORC, HR T3 vs. T1 = 0.58 (0.38, 0.89).
Conclusions
In this Mediterranean cohort, we observed a significant inverse association between a better global quality of carbohydrate intake and the risk of obesity-related cancers. This finding suggests that strategies for cancer prevention should emphasize the quality of carbohydrate intake, and particularly the dietary fibre intake.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
University of Navarra.
Funding
Spanish Government-Instituto de Salud Carlos III, and the European Regional Development Fund (FEDER) (RD 06/0045, CIBER-OBN, Grants PI10/02658, PI10/02293, PI13/00615, PI14/01668, PI14/01798, PI14/01764, PI17/01795, PI20/00564 and G03/140), the Navarra Regional Government (27/2011, 45/2011, 122/2014), and the University of Navarra.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1746P - Unintended consequences: Working time directives and oncology staff implications
Presenter: Simon Barry
Session: Poster session 23
1747P - The need for a better discussion between doctors and patients with regards to fertility preservation and vaginal rehab after anti cervical cancer treatments
Presenter: Bar Levy
Session: Poster session 23
1748P - Tackling childhood obesity epidemic on southern Europe through soft drink advertisement policies: Should oncology societies have a say?
Presenter: Konstantinos Kamposioras
Session: Poster session 23
1749P - Prevention of modifiable cancer risks in informal family caregivers of cancer patients: Implementation and evaluation of a personalised primary prevention intervention (PREV-AIDANT)
Presenter: Beatrice Fervers
Session: Poster session 23
1751P - Re-ranking cancer mortality using years of life lost
Presenter: Cecilia Radkiewicz
Session: Poster session 23
1752P - Clinical benefit of immunotherapies in advanced cancer in France: A population-based estimate from 2014 to 2021
Presenter: Isabelle Borget
Session: Poster session 23
1753P - Universal DPYD genotyping in patients with gastrointestinal malignancies: Real-world data from a single institution in Italy
Presenter: Claudia Cardone
Session: Poster session 23
1754P - Towards a next-generation sequencing/comprehensive genomic profiling value framework: Systematic review for identifying new domains and adapting a diagnostic test value framework in Europe
Presenter: Federico Augustovski
Session: Poster session 23
1756P - Vizcan: A Swedish population-based study to address cancer outcomes using an interactive platform
Presenter: Anders Berglund
Session: Poster session 23